Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer

참고문헌 (200)

1. Raymond, J., "The effect of oxygen on biochemical networks and the evolution of complex life", Science, 311, pp.1764~1767 (2006)
2. Wicks, E. E., "Hypoxia-inducible factors : cancer progression and clinical translation", J. Clin. Investig, 132, pp.e159839~ (2022)
3. Halliwell, B., "Biochemistry of oxidative stress", Biochem Soc. Trans, 35, pp.1147~1150 (2007)
4. Semenza, G. L., "Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics", Oncogene, 29, pp.625~634 (2010)
5. Yamamoto, M., "The KEAP1-NRF2 system : a thiol based sensor-effector apparatus for maintaining redox homeostasis", Physiol. Rev, 98, pp.1169~1203 (2018)
6. O’Malley, J., "Mitochondrial stress response and cancer", Trends Cancer, 6, pp.688~701 (2020)
7. Vaupel, P., "Detection and characterization of tumor hypoxia using pO2 histography", Antioxid. Redox Signal, 9, pp.1221~1235 (2007)
8. Nakamura, H., "Reactive oxygen species in cancer : current findings and future directions", Cancer Sci, 112, pp.3945~3952 (2021)
9. Rojo de la Vega, M., "NRF2 and the hallmarks of cancer", Cancer Cell, 34, pp.21~43 (2018)
10. Hermes-Lima, M., "Preparation for oxidative stress under hypoxia and metabolic depression : revisiting the proposal two decades later", Free Radic. Biol. Med, 89, pp.1122~1143 (2015)
11. Lee, G., "Oxidative dimerization of PHD2 is responsible for its inactivation and contributes to metabolic reprogramming via HIF-1α activation", Sci. Rep, 6, pp.18928~ (2016)
12. Fukuda, R., "HIF-1 regulates cytochrome oxidase subunits to optimize effi ciency of respiration in hypoxic cells", Cell, 129, pp.111~122 (2007)
13. Semenza, G. L., "The genomics and genetics of oxygen homeostasis", Annu. Rev. Genomics Hum. Genet, 21, pp.183~204 (2020)
14. Wang, G. L., "Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension", Proc. Natl Acad. Sci. USA, 92, pp.5510~5514 (1995)
15. Schofield, C. J., "Oxygen sensing by HIF hydroxylases", Nat. Rev. Mol. Cell Biol, 5, pp.343~354 (2004)
16. Bruick, R. K., "A conserved family of prolyl-4-hydroxylases that modify HIF", Science, 294, pp.1337~1340 (2001)
17. Appelhoff, R. J., "Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor*", J. Biol. Chem, 279, pp.38458~38465 (2004)
18. Mahon, P. C., "FIH-1 : a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity", Genes Dev, 15, pp.2675~2686 (2001)
19. Cowman, S. J., "Revisiting the HIF switch in the tumor and its immune microenvironment", Trends Cancer, 8, pp.28~42 (2022)
20. Holmquist-Mengelbier, L., "Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma : HIF-2α promotes an aggressive phenotype", Cancer Cell, 10, pp.413~423 (2006)
21. Koh, M. Y., "Passing the baton: the HIF switch", Trends Biochem. Sci, 37, pp.364~372 (2012)
22. Manalo, D. J., "Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1", Blood, 105, pp.659~669 (2005)
23. Semenza, G. L., "Hypoxia-inducible factors : mediators of cancer progression and targets for cancer therapy", Trends Pharm. Sci, 33, pp.207~214 (2012)
24. Covello, K. L., "HIF-2α regulates Oct-4 : effects of hypoxia on stem cell function, embryonic development, and tumor growth", Genes Dev, 20, pp.557~570 (2006)
25. Sowter, H. M., "HIF-1dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors", Cancer Res, 61, pp.6669~6673 (2001)
26. Dodson, M., "Modulating NRF2 in disease : timing is everything", Annu. Rev. Pharm. Toxicol, 59, pp.555~575 (2019)
27. Torrente, L., "Targeting NRF2 and its downstream processes : opportunities and challenges", Annu. Rev. Pharm. Toxicol, 62, pp.279~300 (2022)
28. Ho, Y. S., "Antioxidant enzyme expression in rat lungs during hyperoxia", Am. J. Physiol, 270, pp.L810~L818 (1996)
29. Cho, H. Y., "Gene expression profiling of NRF2-mediated protection against oxidative injury", Free Radic. Biol. Med, 38, pp.325~343 (2005)
30. Papaiahgari, S., "Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt", ERK MAP kinase signaling in pulmonary epithelial cells, 2006, pp.8, 43~52
31. Taguchi, K., "The KEAP1-NRF2 system in cancer", Front. Oncol, 7, pp.85~ (2017)
32. Rada, P., "Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3", β-TrCP axis, 2012, pp.32, 3486~3499
33. Suzuki, T., "Molecular basis of the KEAP1-NRF2signaling pathway", Mol. Cells, 46, pp.133~141 (2023)
34. Iso, T., "Absolute amounts and status of the Nrf2-Keap1-Cul3 complex within cells", Mol. Cell Biol, 36, pp.3100~3112 (2016)
35. Baird, L., "The molecular mechanisms regulating the KEAP1NRF2 pathway", Mol. Cell Biol, 40, pp.e00099–20~ (2020)
36. Horie, Y., "Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism", Commun. Biol, 4, pp.576~ (2021)
37. Hayes, J. D., "The Nrf2 regulatory network provides an interface between redox and intermediary metabolism", Trends Biochem. Sci, 39, pp.199~218 (2014)
38. Hernansanz-Agustín, P., "Acute hypoxia produces a superoxide burst in cells", Free Radic. Biol. Med, 71, pp.146~156 (2014)
39. Chandel, N. S., "Mitochondrial reactive oxygen species trigger hypoxia induced transcription", Proc. Natl Acad. Sci. USA, 95, pp.11715~11720 (1998)
40. Guzy, R. D., "Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing", Cell Metab, 1, pp.401~408 (2005)
41. Toth, R. K., "Strange bedfellows : nuclear factor, erythroid 2-like 2(Nrf2)and hypoxia-inducible factor 1(HIF-1)in tumor hypoxia", Antioxidants, 6, pp.27~ (2017)
42. Tello, D., "Induction of the mitochondrial NDUFA4L2 protein by HIF-1αdecreases oxygen consumption by inhibiting Complex I activity", Cell Metab, 14, pp.768~779 (2011)
43. Xin, X., "Hesperidin ameliorates hypobaric hypoxia-induced retinal impairment through activation of Nrf2", HO-1 pathway and inhibition of apop tosis, 2020, pp.10, 19426~
44. Potteti, H. R., "Nrf2-AKT interactions regulate heme oxygenase 1 expression in kidney epithelia during hypoxia and hypoxia-reoxygenation", Am. J. Physiol. Ren. Physiol, 311, pp.F1025~f1034 (2016)
45. Kim, T. -H., "NRF2 blockade suppresses colon tumor angiogenesis by inhi biting hypoxia-induced activation of HIF-1α", Cancer Res, 71, pp.2260~2275 (2011)
46. Bondi, C. D., "Suppression of NRF2 Activity by HIF-1⍺ promotes fibrosis after ischemic acute kidney injury", Antioxidants, 11, pp.1810~ (2022)
47. Loboda, A., "HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells", Antioxid. Redox Signal, 11, pp.1501~1517 (2009)
48. Pan, Y., "Multiple factors affecting cellular redox status and energy meta bolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro", Mol. Cell Biol, 27, pp.912~925 (2007)
49. Watanabe, Y., "Glutathione adducts induced by ischemia and deletion of glutaredoxin-1 stabilize HIF-1α and improve limb revascularization", Proc. Natl Acad. Sci. USA, 113, pp.6011~6016 (2016)
50. Hamanaka, R. B., "The mitochondrial respiratory chain is required for organismal adaptation to hypoxia", Cell Rep, 15, pp.451~459 (2016)
51. Bi, Z., "Nrf2 and HIF1α converge to arsenic-induced metabolic reprogram ming and the formation of the cancer stem-like cells", Theranostics, 10, pp.4134~4149 (2020)
52. Ji, X., "Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhi biting hypoxia-induced activation of HIF-1α", Int. J. Cancer, 135, pp.574~584 (2014)
53. Shen, H., "Blockage of Nrf2 suppresses the migration and invasion of eso phageal squamous cell carcinoma cells in hypoxic microenvironment", Dis. Eso phagus, 27, pp.685~692 (2014)
54. Zhang, Z., "Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epi thelial ovarian cancer", Oncol. Rep, 29, pp.1429~1434 (2013)
55. Zheng, J., "Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1alpha", Free Radic. Biol. Med, 194, pp.347~356 (2023)
56. Jin, X., "Enhancer-bound Nrf2 licenses HIF-1alpha transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells", Aging(Albany NY), 13, pp.364~375 (2020)
57. Lacher, S. E., "Identification of a func tional antioxidant response element at the HIF1A locus", Redox. Biology, 19, pp.401~411 (2018)
58. Oh, E. T., "NQO1 inhibits proteasome-mediated degradation of HIF-1α", Nat. Commun, 7, pp.13593~ (2016)
59. Csiki, I., "Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer", Cancer Res, 66, pp.143~150 (2006)
60. Malec, V., "HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549cells", Free Radic. Biol. Med, 48, pp.1626~1635 (2010)
61. Chin, B. Y., "Hypoxia-inducible factor 1alpha stabilization by carbon mon oxide results in cytoprotective preconditioning", Proc. Natl Acad. Sci. USA, 104, pp.5109~5114 (2007)
62. Choi, Y. K., "Carbon monoxide promotes VEGF expression by increasing HIF 1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein", J. Biol. Chem, 285, pp.32116~32125 (2010)
63. Jung, J., "Mitochondrial NIX promotes tumor survival in the hypoxic niche of glioblastoma", Cancer Res, 79, pp.5218~5232 (2019)
64. Jung, K. A., "NFE2L2", NRF2 activity is linked to mitochondria and AMP-activated protein kinase signaling in cancers through miR-181c, Antioxid. Redox Signal, pp.2017, 27[DOI]
65. Lee, S., "Impairment of HIF-1αmediated metabolic adaption by NRF2-silencing in breast cancer cells", Redox Biol, 24, pp.101210~ (2019)
66. Hallis, S. P., "Association of NRF2 with HIF-2αinduced cancer stem cell phenotypes in chronic hypoxic condition", Redox Biol, 60, pp.102632~ (2023)
67. Sullivan, L. B., "The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling", Mol. Cell, 51, pp.236~248 (2013)
68. Early, J. O., "Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2", Proc. Natl Acad. Sci. USA, 115, pp.E8460~E8468 (2018)
69. Di Gregorio, J., "UBXN7 cofactor of CRL3KEAP1 and CRL2VHL ubiquitin ligase complexes mediates reciprocal regulation of NRF2 and HIF-1α proteins", Biochim. Biophys. Acta, 1868, pp.118963~ (2021)
70. Lu, C., "Nrf2 activation is required for ligustrazine to inhibit hepatic steatosis in alcohol-preferring mice and hepatocytes", Toxicol. Sci, 155, pp.432~443 (2017)
71. Li, Y., "Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia", reperfusion-induced acute lung injury, 2020, pp.27, 2635~2650
72. Lin, H. C., "Andrographolide inhibits hypoxia-induced HIF-1α-driven endo thelin 1 secretion by activating Nrf2", HO-1 and promoting the expression of prolyl hydroxylases 2, Environ. Toxicol, pp.2017, 32[DOI]
73. Talks, K. L., "The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages", Am. J. Pathol, 157, pp.411~421 (2000)
74. Schito, L., "Hypoxia-inducible factors : master regulators of cancer progression", Trends Cancer, 2, pp.758~770 (2016)
75. Krieg, M., "Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF 2alpha under normoxic conditions in renal carcinoma cells by von Hippel Lindau tumor suppressor gene loss of function", Oncogene, 19, pp.5435~5443 (2000)
76. Ravi, R., "Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α", Genes Dev, 14, pp.34~44 (2000)
77. Zhong, H., "Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor", phosphatidylinositol 3-kinase, AKT, pp.FRAP path way in human prostate cancer cells : implications for tumor angiogenesis and therapeutics1, Cancer Res[DOI]
78. Isaacs, J. S., "HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer : Novel role of fumarate in regulation of HIF stability", Cancer Cell, 8, pp.143~153 (2005)
79. Greco, S., "HypoxamiR regulation and function in ischemic cardiovascular diseases", Antioxid. Redox Signal, 21, pp.1202~1219 (2014)
80. Menegon, S., "The dual roles of NRF2 in cancer", Trends Mol. Med, 22, pp.578~593 (2016)
81. Robertson, H., "NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis", Cancers(Basel), 12, pp.3609~ (2020)
82. Kitamura, H., "NRF2 addiction in cancer cells", Cancer Sci, 109, pp.900~911 (2018)
83. Guichard, C., "Integrated analysis of somatic mutations and focal copy number changes identifies key genes and pathways in hepatocellular carci noma", Nat. Genet, 44, pp.694~698 (2012)
84. Network, C.G.A.R., "Comprehensive molecular profiling of lung adenocarcinoma", Nature, 511, pp.543~550 (2014)
85. Shibata, T., "Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer", Gastroenterology, 135, pp.1358~1368 (2008)
86. Muscarella, L. A., "Frequent epigenetics inactivation of KEAP1 gene in non small cell lung cancer", Epigenetics, 6, pp.710~719 (2011)
87. DeNicola, G. M., "Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis", Nature, 475, pp.106~109 (2011)
88. Komatsu, M., "The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1", Nat. Cell Biol, 12, pp.213~223 (2010)
89. Adam, J., "Renal cyst formation in Fh1-deficient mice is independent of the Hif", Phd pathway : roles for fumarate in KEAP1 succination and Nrf2 signaling, 2011, pp.20, 524~537
90. Ji, X., "Correlation of Nrf2 and HIF-1alpha in glioblastoma and their rela tionships to clinicopathologic features and survival", Neurol. Res, 35, pp.1044~1050 (2013)
91. Papandreou, I., "HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen con sumption", Cell Metab, 3, pp.187~197 (2006)
92. Semenza, G. L., "Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1", J. Biol. Chem, 269, pp.23757~23763 (1994)
93. Sakagami, H., "Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells", Am. J. Physiol. Endocrinol. Metab, 306, pp.E1065~E1076 (2014)
94. Bellot, G., "Hypoxia-induced autophagy is mediated through hypoxia inducible factor induction of BNIP3 and BNIP3L via their BH3 domains", Mol. Cell Biol, 29, pp.2570~2581 (2009)
95. Chee, N. T., "mRNA-to-protein translation in hypoxia", Mol. Cancer, 18, pp.49~ (2019)
96. Singh, A., "Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance", Antioxid. Redox Signal, 13, pp.1627~1637 (2010)
97. Malhotra, D., "Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network ana lysis", Nucleic Acids Res, 38, pp.5718~5734 (2010)
98. Zhang, H. S., "NRF2 facilitates breast cancer cell growth via HIF1a-mediated metabolic reprogramming", Int. J. Biochem. Cell Biol, 95, pp.85~92 (2018)
99. Zhang, H. S., "Nrf2 promotes breast cancer cell migration via up-regulation of G6PD", HIF-1alpha, J. Cell Mol. Med, pp.2019, 23[DOI]
100. Yang, Y., "Abnormal phenotype of Nrf2 is associated with poor prognosis through hypoxic", VEGF-A-Rap1b, Aging (Albany NY), pp.2022, 14[DOI]
101. Takamiya, R., "The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin beta1-induced tumor progression by blocking of the HIF-1and Nrf2 pathway", Biochem. Biophys. Res. Commun, 454, pp.364~368 (2014)
102. Kazi, A. A., "Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer", Breast Cancer Res, 16, pp.R15~ (2014)
103. Liu, L., "Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer", Cancer Sci, 99, pp.121~128 (2008)
104. Chen, N., "BCL-xL is a target gene regulated by hypoxia-inducible factor 1alpha", J. Biol. Chem, 284, pp.10004~10012 (2009)
105. Erler, J. T., "Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and-independent mechan isms and contributes to drug resistance", Mol. Cell Biol, 24, pp.2875~2889 (2004)
106. Yang, T., "A targeted proteomics approach to the quantitative analysis of ERK", Bcl-2-mediated anti-apoptosis and multi drug resistance in breast cancer, 2016, pp.408, 7491~7503
107. Choi, B.-h, "Shadows of NRF2 in cancer: resistance to chemother apy", Curr. Opin. Toxicol, 1, pp.20~28 (2016)
108. Homma, S., "Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer", Clin. Cancer Res, 15, pp.3423~3432 (2009)
109. Kurz, E. U., "Identification of DNA–protein interactions in the 5′ Flanking and 5′ Untranslated Regions of the Human Multidrug Resis tance Protein(MRP1)gene : evaluation of a putative antioxidant response ele ment", AP-1 binding site, 2001, pp.285, 981~990
110. Singh, A., "Expression of ABCG2(BCRP)is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype", Mol. Cancer Ther, 9, pp.2365~2376 (2010)
111. Niture, S. K., "Nrf2 protein up-regulates antiapoptotic protein Bcl-2and prevents cellular apoptosis", J. Biol. Chem, 287, pp.9873~9886 (2012)
112. Duan, X., "Nrf2-siRNA enhanced the anti-tumor effects of As(2)O(3)in 5f luorouracil-resistant hepatocellular carcinoma by inhibiting HIF-1alpha", HSP70 signaling, 2022, pp.9, 1341~1352
113. Hanahan, D., "Patterns and emerging mechanisms of the angio genic switch during tumorigenesis", Cell, 86, pp.353~364 (1996)
114. Forsythe, J. A., "Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1", Mol. Cell. Biol, 16, pp.4604~4613 (1996)
115. Ceradini, D. J., "Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1", Nat. Med, 10, pp.858~864 (2004)
116. Gao, C., "SCF, regulated by HIF-1α, promotes pancreatic ductal adeno carcinoma cell progression", PLoS ONE, 10, pp.e0121338~ (2015)
117. Simon, M. -P., "The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1", J. Cell. Physiol, 217, pp.809~818 (2008)
118. Florczyk, U., "Nrf2 regulates angiogenesis : effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia", Antioxid. Redox Signal, 20, pp.1693~1708 (2013)
119. Ichihara, S., "Ablation of the transcription factor Nrf2 promotes ischemia induced neovascularization by enhancing the inflammatory response", Arter ioscler. Thromb. Vasc. Biol, 30, pp.1553~1561 (2010)
120. Wei, Y., "Nrf2 acts cell-autonomously in endothelium to regulate tip cell for mation and vascular branching", Proc. Natl Acad. Sci. USA, 110, pp.E3910~E3918 (2013)
121. Li, L., "Interplay between VEGF and Nrf2 regulates angiogenesis due to intracranial venous hypertension", Sci. Rep, 6, pp.37338~ (2016)
122. Feng, R., "Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction", Cell Commun. Signal, 16, pp.54~ (2018)
123. Shao, S., "Curcumin suppresses hepatic stellate cell-induced hepatocarci noma angiogenesis and invasion through downregulating CTGF", Oxid. Med. Cell. Longev, 2019, pp.8148510~ (2019)
124. Hapke, R. Y., "Hypoxia-induced epithelial to mesenchymal transi tion in cancer", Cancer Lett, 487, pp.10~20 (2020)
125. Zhong, H., "Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases", Cancer Res, 59, pp.5830~5835 (1999)
126. Xu, X., "Snail is a direct target of hypoxia-inducible factor 1α(HIF1α)in hypoxia-induced endothelial to mesenchymal transition of human coronary endothelial cells*", J. Biol. Chem, 290, pp.16653~16664 (2015)
127. Yang, M. -H., "Direct regulation of TWIST by HIF-1α promotes metastasis", Nat. Cell Biol, 10, pp.295~305 (2008)
128. Zhang, W., "HIF-1α promotes epithelial-mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer", PLoS ONE, 10, pp.e0129603~ (2015)
129. Wang, R., "Hypoxia-inducible factor-dependent ADAM12 expression med iates breast cancer invasion and metastasis", Proc. Natl Acad. Sci. USA, 118, pp.e2020490118~ (2021)
130. Wang, H., "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis", Sci. Transl. Med, 8, pp.334ra351~ (2016)
131. Zhang, C., "NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA", ROCK pathway signal transduction, 2016, pp.7, 73593~73606
132. Jeong, Y., "Role of KEAP1", NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance, 2017, pp.7, 86~101
133. Yazaki, K., "ROS-Nrf2 pathway mediates the development of TGF-β1induced epithelial-mesenchymal transition through the activation of Notch signaling", Eur. J. Cell Biol, 100, pp.151181~ (2021)
134. Vilchez Mercedes, S. A., "Nrf2 modulates the hybrid epithelial", mesenchymal phenotype and notch signaling during collective cancer migration, 2022, pp.9, 807324~
135. Rachakonda, G., "Increased cell migration and plasticity in Nrf2-deficient cancer cell lines", Oncogene, 29, pp.3703~3714 (2010)
136. Ryu, D., "NRF2 level is negatively correlated with TGF-β1induced lung cancer motility and migration via NOX4-ROS signaling", Arch. Pharmacal Res, 43, pp.1297~1310 (2020)
137. Batlle, E., "Cancer stem cells revisited", Nat. Med, 23, pp.1124~1134 (2017)
138. Yang, L., "Targeting cancer stem cell pathways for cancer therapy", Signal Transduct. Target. Ther, 5, pp.8~ (2020)
139. Wright, M. H., "Brca1 breast tumors contain distinct CD44+", CD24-and CD133+cells with cancer stem cell characteristics, 2008, pp.10, R10~
140. Dalerba, P., "Phenotypic characterization of human colorectal cancer stem cells", Proc. Natl Acad. Sci. USA, 104, pp.10158~10163 (2007)
141. Heddleston, J. M., "Hypoxia inducible factors in cancer stem cells", Br. J. Cancer, 102, pp.789~795 (2010)
142. Samanta, D., "Hypoxia inducible factors are required for chemotherapy resistance of breast cancer stem cells", Proc. Natl Acad. Sci. USA, 111, pp.E5429~E5438 (2014)
143. Conley, S. J., "Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia", Proc. Natl Acad. Sci. USA, 109, pp.2784~2789 (2012)
144. Keith, B., "Hypoxia-inducible factors, stem cells, and cancer", Cell, 129, pp.465~472 (2007)
145. Covello, K. L., "HIF-2alpha regulates Oct-4 : effects of hypoxia on stem cell function, embryonic development, and tumor growth", Genes Dev, 20, pp.557~570 (2006)
146. Lu, H., "Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4mediated breast cancer stemness", J. Clin. Investig, 130, pp.4607~4623 (2020)
147. Qin, J., "Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression", Sci. Rep, 7, pp.10592~ (2017)
148. Yan, Y., "HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways", J. Exp. Clin. Cancer Res, 37, pp.256~ (2018)
149. Yan, Y., "A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI", GPR78-UPR(ER)axis, 2022, pp.29, 1769~1789
150. Micucci, C., "HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma", Br. J. Cancer, 113, pp.1178~1185 (2015)
151. Diehn, M., "Association of reactive oxygen species levels and radioresistance in cancer stem cells", Nature, 458, pp.780~783 (2009)
152. Hallis, S. P., "Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype", Mol. Cells, 46, pp.153~164 (2023)
153. Chang, C. -W., "ROS-independent ER stress-mediated NRF2 activation pro motes warburg effect to maintain stemness-associated properties of cancer initiating cells", Cell Death Dis, 9, pp.194~ (2018)
154. Chang, C. W., "Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity", Cancer Res, 74, pp.6291~6305 (2014)
155. Gao, L., "Nrf2 signaling promotes cancer stemness, migration, and expres sion of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells", PLoS ONE, 16, pp.e0256755~ (2021)
156. Zhu, J., "Nrf2 is required to maintain the self-renewal of glioma stem cells", BMC Cancer, 13, pp.380~ (2013)
157. Ryoo, I.-g, "High CD44 expression mediates p62associated NFE2L2", NRF2 activation in breast cancer stem cell-like cells: impli cations for cancer stem cell resistance, 2018, pp.17, 246~258
158. Park, J., "Role of CD133", NRF2 axis in the development of colon cancer stem cell-like properties, 2022, pp.11, 808300~
159. Kim, D., "High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase(ALDH)-high ovarian can cer cells : inhibitory role of all-trans retinoic acid in ALDH", NRF2 signaling, 2018, pp.9, 896~
160. Noman, A. S. M., "Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6", p62 associated Nrf2-antioxidant pathway activation, 2020, pp.11, 663~
161. Okazaki, K., "Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers", Nat. Commun, 11, pp.5911~ (2020)
162. Kim, D. H., "Nuclear factor erythroid-derived 2-like 2-induced reductive stress favors self-renewal of breast cancer stem-like cells via the FoxO3a-Bmi-1axis", Antioxid. Redox Signal, 32, pp.1313~1329 (2020)
163. Fragoulis, A., "Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression", Redox Biol, 57, pp.102453~ (2022)
164. Zhang, G., "Hypoxia-driven M2-polarized macrophages facilitate cancer aggressiveness and temozolomide resistance in glioblastoma", Oxid. Med. Cell. Longev, 2022, pp.1614336~ (2022)
165. Kipp, A. P., "Time-and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells", Redox Biol, 12, pp.403~409 (2017)
166. Dixon, Scott J., "Ferroptosis : an iron-dependent form of nonapoptotic cell death", Cell, 149, pp.1060~1072 (2012)
167. Li, J., "Ferroptosis : past, present and future", Cell Death Dis, 11, pp.88~ (2020)
168. Yang, W. S., "Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells", Chem. Biol, 15, pp.234~245 (2008)
169. Friedmann Angeli, J. P., "Inactivation of the ferroptosis regulator Gpx4triggers acute renal failure in mice", Nat. Cell Biol, 16, pp.1180~1191 (2014)
170. Viswanathan, V. S., "Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway", Nature, 547, pp.453~457 (2017)
171. Fuhrmann, D. C., "Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis", Redox Biol, 36, pp.101670~ (2020)
172. Miess, H., "The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma", Oncogene, 37, pp.5435~5450 (2018)
173. Green, Y. S., "ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma", Oncogene, 41, pp.4709~4723 (2022)
174. Yang, M., "Clockophagy is a novel selective autophagy process favoring ferroptosis", Sci. Adv, 5, pp.eaaw2238~ (2019)
175. Singhal, R., "HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron", J. Clin. Invest, 131, pp.e143691~ (2021)
176. Su, X., "HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis", Cell Death Dis, 13, pp.861~ (2022)
177. Dodson, M., "NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis", Redox Biol, 23, pp.101107~ (2019)
178. Fan, Z., "Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis", Oncogenesis, 6, pp.e371~e371 (2017)
179. Shin, D., "Nrf2 inhibition reverses resistance to GPX4inhibitor-induced ferroptosis in head and neck cancer", Free Radic. Biol. Med, 129, pp.454~462 (2018)
180. Yang, J., "Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2", HO-1 signalling pathway in KRAS mutant colorectal cancer, 2021, pp.12, 1079~
181. Koppula, P., "A targetable CoQ-FSP1 axis drives ferroptosis-and radiation resistance in KEAP1 inactive lung cancers", Nat. Commun, 13, pp.2206~ (2022)
182. Anandhan, A., "NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8", Sci. Adv, 9, pp.eade9585~ (2023)
183. Chen, L. D., "Nrf2 plays protective role during intermittent hypoxia-induced ferroptosis in rat liver(BRL-3A)cells", Sleep. Breath, 27, pp.2069~2076 (2023)
184. Li, D., "Silencing TRPM2 enhanced erastin-and RSL3-induced ferroptosis in gastric cancer cells through destabilizing HIF-1α and Nrf2 proteins", Cyto technology, 74, pp.559~577 (2022)
185. Kikuchi, H., "Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and-2alpha in colon cancer", Cancer Res, 69, pp.8499~8506 (2009)
186. Cahuzac, K. M., "AKT activation because of PTEN loss upregulates xCT via GSK3β", NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells, 2023, pp.42, 112536~
187. Kang, H. J., "HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction", Sci. Rep, 4, pp.7201~ (2014)
188. Lu, Y., "Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells", Sci. Rep, 6, pp.39123~ (2016)
189. Chen, F., "Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1alpha and Nrf2", Pharmacogenomics, 14, pp.1305~1317 (2013)
190. Liu, Y., "Low-dose triptolide in combination with idarubicin induces apop tosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors", Cell Death Dis, 4, pp.e948~ (2013)
191. Jin, J., "Cardamonin inhibits breast cancer growth by repressing HIF-1alpha dependent metabolic reprogramming", J. Exp. Clin. Cancer Res, 38, pp.377~ (2019)
192. Qu, J., "miR-148b functions as a tumor suppressor by targeting endoplasmic reticulum metallo protease 1 in human endometrial cancer cells", Oncol. Res, 27, pp.81~88 (2018)
193. Kuper, A., "Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis", Cell Death Dis, 12, pp.82~ (2021)
194. Wakabayashi, N., "Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration", Sci. Signal, 3, pp.ra52–ra52~ (2010)
195. He, F., "NRF2, a Transcription Factor for Stress Response and Beyond", Int. J. Mol. Sci, 21, pp.4777~ (2020)
196. Gustafsson, M. V., "Hypoxia requires notch signaling to maintain the undifferentiated cell state", Develop. Cell, 9, pp.617~628 (2005)
197. Lv, Y., "Hypoxia-inducible factor-1alpha induces multidrug resistance pro tein in colon cancer", Onco Targets Ther, 8, pp.1941~1948 (2015)
198. Lee, P. J., "Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia*", J. Biol. Chem, 272, pp.5375~5381 (1997)
199. Jang, J., "Primary cilium-autophagy-Nrf2(PAN)axis activation commits human embryonic stem cells to a neuroectoderm fate", Cell, 165, pp.410~420 (2016)
200. Petruzzelli, R., "HIF 2α regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox cis regulatory element", PLoS ONE, 9, pp.e108309~ (2014)

관련 논문AI추천